Global Biomanufacturing in Pharmaceutical Market Research Report 2025

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biomanufacturing in Pharmaceutical Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Antibody Drugs
1.2.3 Recombinant Protein Drugs
1.2.4 Blood Products
1.2.5 Vaccine Preparations
1.2.6 CAR-T Drugs
1.2.7 Small Nucleic Acid Drugs
1.2.8 Others
1.3 Market by Class
1.3.1 Global Biomanufacturing in Pharmaceutical Market Size Growth Rate by Class: 2020 VS 2024 VS 2031
1.3.2 Monoclonal Antibodies
1.3.3 Antibody-drug Conjugates (ADCs)
1.3.4 Peptide Drugs
1.3.5 Enzyme Replacement Therapy
1.3.6 Human Albumin
1.3.7 Immunoglobulins
1.3.8 Coagulation Factors
1.3.9 COVID-19 Vaccines
1.3.10 Other Vaccines
1.4 Market by Application
1.4.1 Global Biomanufacturing in Pharmaceutical Market Growth by Application: 2020 VS 2024 VS 2031
1.4.2 Oncology
1.4.3 Infectious Diseases
1.4.4 Immune and Inflammatory Diseases
1.4.5 Endocrine and Metabolic Diseases
1.4.6 Neurological Diseases
1.4.7 Hematologic Diseases
1.4.8 Others
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Biomanufacturing in Pharmaceutical Market Perspective (2020-2031)
2.2 Global Biomanufacturing in Pharmaceutical Growth Trends by Region
2.2.1 Global Biomanufacturing in Pharmaceutical Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Biomanufacturing in Pharmaceutical Historic Market Size by Region (2020-2025)
2.2.3 Biomanufacturing in Pharmaceutical Forecasted Market Size by Region (2026-2031)
2.3 Biomanufacturing in Pharmaceutical Market Dynamics
2.3.1 Biomanufacturing in Pharmaceutical Industry Trends
2.3.2 Biomanufacturing in Pharmaceutical Market Drivers
2.3.3 Biomanufacturing in Pharmaceutical Market Challenges
2.3.4 Biomanufacturing in Pharmaceutical Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biomanufacturing in Pharmaceutical Players by Revenue
3.1.1 Global Top Biomanufacturing in Pharmaceutical Players by Revenue (2020-2025)
3.1.2 Global Biomanufacturing in Pharmaceutical Revenue Market Share by Players (2020-2025)
3.2 Global Top Biomanufacturing in Pharmaceutical Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Biomanufacturing in Pharmaceutical Revenue
3.4 Global Biomanufacturing in Pharmaceutical Market Concentration Ratio
3.4.1 Global Biomanufacturing in Pharmaceutical Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biomanufacturing in Pharmaceutical Revenue in 2024
3.5 Global Key Players of Biomanufacturing in Pharmaceutical Head office and Area Served
3.6 Global Key Players of Biomanufacturing in Pharmaceutical, Product and Application
3.7 Global Key Players of Biomanufacturing in Pharmaceutical, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biomanufacturing in Pharmaceutical Breakdown Data by Type
4.1 Global Biomanufacturing in Pharmaceutical Historic Market Size by Type (2020-2025)
4.2 Global Biomanufacturing in Pharmaceutical Forecasted Market Size by Type (2026-2031)
5 Biomanufacturing in Pharmaceutical Breakdown Data by Application
5.1 Global Biomanufacturing in Pharmaceutical Historic Market Size by Application (2020-2025)
5.2 Global Biomanufacturing in Pharmaceutical Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Biomanufacturing in Pharmaceutical Market Size (2020-2031)
6.2 North America Biomanufacturing in Pharmaceutical Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Biomanufacturing in Pharmaceutical Market Size by Country (2020-2025)
6.4 North America Biomanufacturing in Pharmaceutical Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biomanufacturing in Pharmaceutical Market Size (2020-2031)
7.2 Europe Biomanufacturing in Pharmaceutical Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Biomanufacturing in Pharmaceutical Market Size by Country (2020-2025)
7.4 Europe Biomanufacturing in Pharmaceutical Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Biomanufacturing in Pharmaceutical Market Size (2020-2031)
8.2 Asia-Pacific Biomanufacturing in Pharmaceutical Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Biomanufacturing in Pharmaceutical Market Size by Region (2020-2025)
8.4 Asia-Pacific Biomanufacturing in Pharmaceutical Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Biomanufacturing in Pharmaceutical Market Size (2020-2031)
9.2 Latin America Biomanufacturing in Pharmaceutical Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Biomanufacturing in Pharmaceutical Market Size by Country (2020-2025)
9.4 Latin America Biomanufacturing in Pharmaceutical Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biomanufacturing in Pharmaceutical Market Size (2020-2031)
10.2 Middle East & Africa Biomanufacturing in Pharmaceutical Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Biomanufacturing in Pharmaceutical Market Size by Country (2020-2025)
10.4 Middle East & Africa Biomanufacturing in Pharmaceutical Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Biomanufacturing in Pharmaceutical Introduction
11.1.4 Roche Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025)
11.1.5 Roche Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Biomanufacturing in Pharmaceutical Introduction
11.2.4 Merck Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025)
11.2.5 Merck Recent Development
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Details
11.3.2 Novo Nordisk Business Overview
11.3.3 Novo Nordisk Biomanufacturing in Pharmaceutical Introduction
11.3.4 Novo Nordisk Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025)
11.3.5 Novo Nordisk Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Biomanufacturing in Pharmaceutical Introduction
11.4.4 Sanofi Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025)
11.4.5 Sanofi Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Biomanufacturing in Pharmaceutical Introduction
11.5.4 Johnson & Johnson Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025)
11.5.5 Johnson & Johnson Recent Development
11.6 AbbVie
11.6.1 AbbVie Company Details
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Biomanufacturing in Pharmaceutical Introduction
11.6.4 AbbVie Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025)
11.6.5 AbbVie Recent Development
11.7 Amgen
11.7.1 Amgen Company Details
11.7.2 Amgen Business Overview
11.7.3 Amgen Biomanufacturing in Pharmaceutical Introduction
11.7.4 Amgen Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025)
11.7.5 Amgen Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Biomanufacturing in Pharmaceutical Introduction
11.8.4 AstraZeneca Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025)
11.8.5 AstraZeneca Recent Development
11.9 Takeda Pharmaceuticals
11.9.1 Takeda Pharmaceuticals Company Details
11.9.2 Takeda Pharmaceuticals Business Overview
11.9.3 Takeda Pharmaceuticals Biomanufacturing in Pharmaceutical Introduction
11.9.4 Takeda Pharmaceuticals Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025)
11.9.5 Takeda Pharmaceuticals Recent Development
11.10 Bristol-Myers Squib
11.10.1 Bristol-Myers Squib Company Details
11.10.2 Bristol-Myers Squib Business Overview
11.10.3 Bristol-Myers Squib Biomanufacturing in Pharmaceutical Introduction
11.10.4 Bristol-Myers Squib Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025)
11.10.5 Bristol-Myers Squib Recent Development
11.11 Pfizer
11.11.1 Pfizer Company Details
11.11.2 Pfizer Business Overview
11.11.3 Pfizer Biomanufacturing in Pharmaceutical Introduction
11.11.4 Pfizer Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025)
11.11.5 Pfizer Recent Development
11.12 Eli Lilly
11.12.1 Eli Lilly Company Details
11.12.2 Eli Lilly Business Overview
11.12.3 Eli Lilly Biomanufacturing in Pharmaceutical Introduction
11.12.4 Eli Lilly Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025)
11.12.5 Eli Lilly Recent Development
11.13 Novartis
11.13.1 Novartis Company Details
11.13.2 Novartis Business Overview
11.13.3 Novartis Biomanufacturing in Pharmaceutical Introduction
11.13.4 Novartis Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025)
11.13.5 Novartis Recent Development
11.14 GSK
11.14.1 GSK Company Details
11.14.2 GSK Business Overview
11.14.3 GSK Biomanufacturing in Pharmaceutical Introduction
11.14.4 GSK Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025)
11.14.5 GSK Recent Development
11.15 CSL Limited
11.15.1 CSL Limited Company Details
11.15.2 CSL Limited Business Overview
11.15.3 CSL Limited Biomanufacturing in Pharmaceutical Introduction
11.15.4 CSL Limited Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025)
11.15.5 CSL Limited Recent Development
11.16 Regeneron Pharmaceuticals
11.16.1 Regeneron Pharmaceuticals Company Details
11.16.2 Regeneron Pharmaceuticals Business Overview
11.16.3 Regeneron Pharmaceuticals Biomanufacturing in Pharmaceutical Introduction
11.16.4 Regeneron Pharmaceuticals Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025)
11.16.5 Regeneron Pharmaceuticals Recent Development
11.17 Gilford
11.17.1 Gilford Company Details
11.17.2 Gilford Business Overview
11.17.3 Gilford Biomanufacturing in Pharmaceutical Introduction
11.17.4 Gilford Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025)
11.17.5 Gilford Recent Development
11.18 Biogen
11.18.1 Biogen Company Details
11.18.2 Biogen Business Overview
11.18.3 Biogen Biomanufacturing in Pharmaceutical Introduction
11.18.4 Biogen Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025)
11.18.5 Biogen Recent Development
11.19 GileadSciences
11.19.1 GileadSciences Company Details
11.19.2 GileadSciences Business Overview
11.19.3 GileadSciences Biomanufacturing in Pharmaceutical Introduction
11.19.4 GileadSciences Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025)
11.19.5 GileadSciences Recent Development
11.20 Moderna
11.20.1 Moderna Company Details
11.20.2 Moderna Business Overview
11.20.3 Moderna Biomanufacturing in Pharmaceutical Introduction
11.20.4 Moderna Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025)
11.20.5 Moderna Recent Development
11.21 Sarepta Therapeutics, Inc.
11.21.1 Sarepta Therapeutics, Inc. Company Details
11.21.2 Sarepta Therapeutics, Inc. Business Overview
11.21.3 Sarepta Therapeutics, Inc. Biomanufacturing in Pharmaceutical Introduction
11.21.4 Sarepta Therapeutics, Inc. Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025)
11.21.5 Sarepta Therapeutics, Inc. Recent Development
11.22 Changchun High-Tech Industry
11.22.1 Changchun High-Tech Industry Company Details
11.22.2 Changchun High-Tech Industry Business Overview
11.22.3 Changchun High-Tech Industry Biomanufacturing in Pharmaceutical Introduction
11.22.4 Changchun High-Tech Industry Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025)
11.22.5 Changchun High-Tech Industry Recent Development
11.23 Sino Biopharmaceutical Limited
11.23.1 Sino Biopharmaceutical Limited Company Details
11.23.2 Sino Biopharmaceutical Limited Business Overview
11.23.3 Sino Biopharmaceutical Limited Biomanufacturing in Pharmaceutical Introduction
11.23.4 Sino Biopharmaceutical Limited Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025)
11.23.5 Sino Biopharmaceutical Limited Recent Development
11.24 Sobi
11.24.1 Sobi Company Details
11.24.2 Sobi Business Overview
11.24.3 Sobi Biomanufacturing in Pharmaceutical Introduction
11.24.4 Sobi Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025)
11.24.5 Sobi Recent Development
11.25 3SBio Inc.
11.25.1 3SBio Inc. Company Details
11.25.2 3SBio Inc. Business Overview
11.25.3 3SBio Inc. Biomanufacturing in Pharmaceutical Introduction
11.25.4 3SBio Inc. Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025)
11.25.5 3SBio Inc. Recent Development
11.26 Beijing Tiantan Biological
11.26.1 Beijing Tiantan Biological Company Details
11.26.2 Beijing Tiantan Biological Business Overview
11.26.3 Beijing Tiantan Biological Biomanufacturing in Pharmaceutical Introduction
11.26.4 Beijing Tiantan Biological Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025)
11.26.5 Beijing Tiantan Biological Recent Development
11.27 Innovent Biologics
11.27.1 Innovent Biologics Company Details
11.27.2 Innovent Biologics Business Overview
11.27.3 Innovent Biologics Biomanufacturing in Pharmaceutical Introduction
11.27.4 Innovent Biologics Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025)
11.27.5 Innovent Biologics Recent Development
11.28 Qilu Pharmaceutical
11.28.1 Qilu Pharmaceutical Company Details
11.28.2 Qilu Pharmaceutical Business Overview
11.28.3 Qilu Pharmaceutical Biomanufacturing in Pharmaceutical Introduction
11.28.4 Qilu Pharmaceutical Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025)
11.28.5 Qilu Pharmaceutical Recent Development
11.29 Boehringer Ingelheim
11.29.1 Boehringer Ingelheim Company Details
11.29.2 Boehringer Ingelheim Business Overview
11.29.3 Boehringer Ingelheim Biomanufacturing in Pharmaceutical Introduction
11.29.4 Boehringer Ingelheim Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025)
11.29.5 Boehringer Ingelheim Recent Development
11.30 BeiGene
11.30.1 BeiGene Company Details
11.30.2 BeiGene Business Overview
11.30.3 BeiGene Biomanufacturing in Pharmaceutical Introduction
11.30.4 BeiGene Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025)
11.30.5 BeiGene Recent Development
11.31 Jiangsu Hengrui Pharmaceuticals
11.31.1 Jiangsu Hengrui Pharmaceuticals Company Details
11.31.2 Jiangsu Hengrui Pharmaceuticals Business Overview
11.31.3 Jiangsu Hengrui Pharmaceuticals Biomanufacturing in Pharmaceutical Introduction
11.31.4 Jiangsu Hengrui Pharmaceuticals Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025)
11.31.5 Jiangsu Hengrui Pharmaceuticals Recent Development
11.32 Hualan Biological
11.32.1 Hualan Biological Company Details
11.32.2 Hualan Biological Business Overview
11.32.3 Hualan Biological Biomanufacturing in Pharmaceutical Introduction
11.32.4 Hualan Biological Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025)
11.32.5 Hualan Biological Recent Development
11.33 Shanghai Henlius Biotech
11.33.1 Shanghai Henlius Biotech Company Details
11.33.2 Shanghai Henlius Biotech Business Overview
11.33.3 Shanghai Henlius Biotech Biomanufacturing in Pharmaceutical Introduction
11.33.4 Shanghai Henlius Biotech Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025)
11.33.5 Shanghai Henlius Biotech Recent Development
11.34 Taibang Biologic
11.34.1 Taibang Biologic Company Details
11.34.2 Taibang Biologic Business Overview
11.34.3 Taibang Biologic Biomanufacturing in Pharmaceutical Introduction
11.34.4 Taibang Biologic Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025)
11.34.5 Taibang Biologic Recent Development
11.35 Gan & Lee Pharmaceuticals
11.35.1 Gan & Lee Pharmaceuticals Company Details
11.35.2 Gan & Lee Pharmaceuticals Business Overview
11.35.3 Gan & Lee Pharmaceuticals Biomanufacturing in Pharmaceutical Introduction
11.35.4 Gan & Lee Pharmaceuticals Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025)
11.35.5 Gan & Lee Pharmaceuticals Recent Development
11.36 Anhui Anke Biotechnology
11.36.1 Anhui Anke Biotechnology Company Details
11.36.2 Anhui Anke Biotechnology Business Overview
11.36.3 Anhui Anke Biotechnology Biomanufacturing in Pharmaceutical Introduction
11.36.4 Anhui Anke Biotechnology Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025)
11.36.5 Anhui Anke Biotechnology Recent Development
11.37 Tonghua Dongbao Pharmaceutical
11.37.1 Tonghua Dongbao Pharmaceutical Company Details
11.37.2 Tonghua Dongbao Pharmaceutical Business Overview
11.37.3 Tonghua Dongbao Pharmaceutical Biomanufacturing in Pharmaceutical Introduction
11.37.4 Tonghua Dongbao Pharmaceutical Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025)
11.37.5 Tonghua Dongbao Pharmaceutical Recent Development
11.38 Shanghai Junshi Biosciences
11.38.1 Shanghai Junshi Biosciences Company Details
11.38.2 Shanghai Junshi Biosciences Business Overview
11.38.3 Shanghai Junshi Biosciences Biomanufacturing in Pharmaceutical Introduction
11.38.4 Shanghai Junshi Biosciences Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025)
11.38.5 Shanghai Junshi Biosciences Recent Development
11.39 Sichuan Yuanda Shuyang Pharmaceutical
11.39.1 Sichuan Yuanda Shuyang Pharmaceutical Company Details
11.39.2 Sichuan Yuanda Shuyang Pharmaceutical Business Overview
11.39.3 Sichuan Yuanda Shuyang Pharmaceutical Biomanufacturing in Pharmaceutical Introduction
11.39.4 Sichuan Yuanda Shuyang Pharmaceutical Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025)
11.39.5 Sichuan Yuanda Shuyang Pharmaceutical Recent Development
11.40 Kexing Biopharm
11.40.1 Kexing Biopharm Company Details
11.40.2 Kexing Biopharm Business Overview
11.40.3 Kexing Biopharm Biomanufacturing in Pharmaceutical Introduction
11.40.4 Kexing Biopharm Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025)
11.40.5 Kexing Biopharm Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Biomanufacturing in Pharmaceutical Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Antibody Drugs
Table 3. Key Players of Recombinant Protein Drugs
Table 4. Key Players of Blood Products
Table 5. Key Players of Vaccine Preparations
Table 6. Key Players of CAR-T Drugs
Table 7. Key Players of Small Nucleic Acid Drugs
Table 8. Key Players of Others
Table 9. Global Biomanufacturing in Pharmaceutical Market Size Growth Rate by Class (US$ Million): 2020 VS 2024 VS 2031
Table 10. Key Players of Monoclonal Antibodies
Table 11. Key Players of Antibody-drug Conjugates (ADCs)
Table 12. Key Players of Peptide Drugs
Table 13. Key Players of Enzyme Replacement Therapy
Table 14. Key Players of Human Albumin
Table 15. Key Players of Immunoglobulins
Table 16. Key Players of Coagulation Factors
Table 17. Global Biomanufacturing in Pharmaceutical Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 18. Global Biomanufacturing in Pharmaceutical Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 19. Global Biomanufacturing in Pharmaceutical Market Size by Region (2020-2025) & (US$ Million)
Table 20. Global Biomanufacturing in Pharmaceutical Market Share by Region (2020-2025)
Table 21. Global Biomanufacturing in Pharmaceutical Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 22. Global Biomanufacturing in Pharmaceutical Market Share by Region (2026-2031)
Table 23. Biomanufacturing in Pharmaceutical Market Trends
Table 24. Biomanufacturing in Pharmaceutical Market Drivers
Table 25. Biomanufacturing in Pharmaceutical Market Challenges
Table 26. Biomanufacturing in Pharmaceutical Market Restraints
Table 27. Global Biomanufacturing in Pharmaceutical Revenue by Players (2020-2025) & (US$ Million)
Table 28. Global Biomanufacturing in Pharmaceutical Market Share by Players (2020-2025)
Table 29. Global Top Biomanufacturing in Pharmaceutical Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biomanufacturing in Pharmaceutical as of 2024)
Table 30. Ranking of Global Top Biomanufacturing in Pharmaceutical Companies by Revenue (US$ Million) in 2024
Table 31. Global 5 Largest Players Market Share by Biomanufacturing in Pharmaceutical Revenue (CR5 and HHI) & (2020-2025)
Table 32. Global Key Players of Biomanufacturing in Pharmaceutical, Headquarters and Area Served
Table 33. Global Key Players of Biomanufacturing in Pharmaceutical, Product and Application
Table 34. Global Key Players of Biomanufacturing in Pharmaceutical, Date of Enter into This Industry
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Biomanufacturing in Pharmaceutical Market Size by Type (2020-2025) & (US$ Million)
Table 37. Global Biomanufacturing in Pharmaceutical Revenue Market Share by Type (2020-2025)
Table 38. Global Biomanufacturing in Pharmaceutical Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 39. Global Biomanufacturing in Pharmaceutical Revenue Market Share by Type (2026-2031)
Table 40. Global Biomanufacturing in Pharmaceutical Market Size by Application (2020-2025) & (US$ Million)
Table 41. Global Biomanufacturing in Pharmaceutical Revenue Market Share by Application (2020-2025)
Table 42. Global Biomanufacturing in Pharmaceutical Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 43. Global Biomanufacturing in Pharmaceutical Revenue Market Share by Application (2026-2031)
Table 44. North America Biomanufacturing in Pharmaceutical Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. North America Biomanufacturing in Pharmaceutical Market Size by Country (2020-2025) & (US$ Million)
Table 46. North America Biomanufacturing in Pharmaceutical Market Size by Country (2026-2031) & (US$ Million)
Table 47. Europe Biomanufacturing in Pharmaceutical Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 48. Europe Biomanufacturing in Pharmaceutical Market Size by Country (2020-2025) & (US$ Million)
Table 49. Europe Biomanufacturing in Pharmaceutical Market Size by Country (2026-2031) & (US$ Million)
Table 50. Asia-Pacific Biomanufacturing in Pharmaceutical Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 51. Asia-Pacific Biomanufacturing in Pharmaceutical Market Size by Region (2020-2025) & (US$ Million)
Table 52. Asia-Pacific Biomanufacturing in Pharmaceutical Market Size by Region (2026-2031) & (US$ Million)
Table 53. Latin America Biomanufacturing in Pharmaceutical Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 54. Latin America Biomanufacturing in Pharmaceutical Market Size by Country (2020-2025) & (US$ Million)
Table 55. Latin America Biomanufacturing in Pharmaceutical Market Size by Country (2026-2031) & (US$ Million)
Table 56. Middle East & Africa Biomanufacturing in Pharmaceutical Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 57. Middle East & Africa Biomanufacturing in Pharmaceutical Market Size by Country (2020-2025) & (US$ Million)
Table 58. Middle East & Africa Biomanufacturing in Pharmaceutical Market Size by Country (2026-2031) & (US$ Million)
Table 59. Roche Company Details
Table 60. Roche Business Overview
Table 61. Roche Biomanufacturing in Pharmaceutical Product
Table 62. Roche Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 63. Roche Recent Development
Table 64. Merck Company Details
Table 65. Merck Business Overview
Table 66. Merck Biomanufacturing in Pharmaceutical Product
Table 67. Merck Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 68. Merck Recent Development
Table 69. Novo Nordisk Company Details
Table 70. Novo Nordisk Business Overview
Table 71. Novo Nordisk Biomanufacturing in Pharmaceutical Product
Table 72. Novo Nordisk Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 73. Novo Nordisk Recent Development
Table 74. Sanofi Company Details
Table 75. Sanofi Business Overview
Table 76. Sanofi Biomanufacturing in Pharmaceutical Product
Table 77. Sanofi Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 78. Sanofi Recent Development
Table 79. Johnson & Johnson Company Details
Table 80. Johnson & Johnson Business Overview
Table 81. Johnson & Johnson Biomanufacturing in Pharmaceutical Product
Table 82. Johnson & Johnson Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 83. Johnson & Johnson Recent Development
Table 84. AbbVie Company Details
Table 85. AbbVie Business Overview
Table 86. AbbVie Biomanufacturing in Pharmaceutical Product
Table 87. AbbVie Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 88. AbbVie Recent Development
Table 89. Amgen Company Details
Table 90. Amgen Business Overview
Table 91. Amgen Biomanufacturing in Pharmaceutical Product
Table 92. Amgen Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 93. Amgen Recent Development
Table 94. AstraZeneca Company Details
Table 95. AstraZeneca Business Overview
Table 96. AstraZeneca Biomanufacturing in Pharmaceutical Product
Table 97. AstraZeneca Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 98. AstraZeneca Recent Development
Table 99. Takeda Pharmaceuticals Company Details
Table 100. Takeda Pharmaceuticals Business Overview
Table 101. Takeda Pharmaceuticals Biomanufacturing in Pharmaceutical Product
Table 102. Takeda Pharmaceuticals Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 103. Takeda Pharmaceuticals Recent Development
Table 104. Bristol-Myers Squib Company Details
Table 105. Bristol-Myers Squib Business Overview
Table 106. Bristol-Myers Squib Biomanufacturing in Pharmaceutical Product
Table 107. Bristol-Myers Squib Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 108. Bristol-Myers Squib Recent Development
Table 109. Pfizer Company Details
Table 110. Pfizer Business Overview
Table 111. Pfizer Biomanufacturing in Pharmaceutical Product
Table 112. Pfizer Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 113. Pfizer Recent Development
Table 114. Eli Lilly Company Details
Table 115. Eli Lilly Business Overview
Table 116. Eli Lilly Biomanufacturing in Pharmaceutical Product
Table 117. Eli Lilly Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 118. Eli Lilly Recent Development
Table 119. Novartis Company Details
Table 120. Novartis Business Overview
Table 121. Novartis Biomanufacturing in Pharmaceutical Product
Table 122. Novartis Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 123. Novartis Recent Development
Table 124. GSK Company Details
Table 125. GSK Business Overview
Table 126. GSK Biomanufacturing in Pharmaceutical Product
Table 127. GSK Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 128. GSK Recent Development
Table 129. CSL Limited Company Details
Table 130. CSL Limited Business Overview
Table 131. CSL Limited Biomanufacturing in Pharmaceutical Product
Table 132. CSL Limited Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 133. CSL Limited Recent Development
Table 134. Regeneron Pharmaceuticals Company Details
Table 135. Regeneron Pharmaceuticals Business Overview
Table 136. Regeneron Pharmaceuticals Biomanufacturing in Pharmaceutical Product
Table 137. Regeneron Pharmaceuticals Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 138. Regeneron Pharmaceuticals Recent Development
Table 139. Gilford Company Details
Table 140. Gilford Business Overview
Table 141. Gilford Biomanufacturing in Pharmaceutical Product
Table 142. Gilford Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 143. Gilford Recent Development
Table 144. Biogen Company Details
Table 145. Biogen Business Overview
Table 146. Biogen Biomanufacturing in Pharmaceutical Product
Table 147. Biogen Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 148. Biogen Recent Development
Table 149. GileadSciences Company Details
Table 150. GileadSciences Business Overview
Table 151. GileadSciences Biomanufacturing in Pharmaceutical Product
Table 152. GileadSciences Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 153. GileadSciences Recent Development
Table 154. Moderna Company Details
Table 155. Moderna Business Overview
Table 156. Moderna Biomanufacturing in Pharmaceutical Product
Table 157. Moderna Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 158. Moderna Recent Development
Table 159. Sarepta Therapeutics, Inc. Company Details
Table 160. Sarepta Therapeutics, Inc. Business Overview
Table 161. Sarepta Therapeutics, Inc. Biomanufacturing in Pharmaceutical Product
Table 162. Sarepta Therapeutics, Inc. Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 163. Sarepta Therapeutics, Inc. Recent Development
Table 164. Changchun High-Tech Industry Company Details
Table 165. Changchun High-Tech Industry Business Overview
Table 166. Changchun High-Tech Industry Biomanufacturing in Pharmaceutical Product
Table 167. Changchun High-Tech Industry Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 168. Changchun High-Tech Industry Recent Development
Table 169. Sino Biopharmaceutical Limited Company Details
Table 170. Sino Biopharmaceutical Limited Business Overview
Table 171. Sino Biopharmaceutical Limited Biomanufacturing in Pharmaceutical Product
Table 172. Sino Biopharmaceutical Limited Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 173. Sino Biopharmaceutical Limited Recent Development
Table 174. Sobi Company Details
Table 175. Sobi Business Overview
Table 176. Sobi Biomanufacturing in Pharmaceutical Product
Table 177. Sobi Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 178. Sobi Recent Development
Table 179. 3SBio Inc. Company Details
Table 180. 3SBio Inc. Business Overview
Table 181. 3SBio Inc. Biomanufacturing in Pharmaceutical Product
Table 182. 3SBio Inc. Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 183. 3SBio Inc. Recent Development
Table 184. Beijing Tiantan Biological Company Details
Table 185. Beijing Tiantan Biological Business Overview
Table 186. Beijing Tiantan Biological Biomanufacturing in Pharmaceutical Product
Table 187. Beijing Tiantan Biological Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 188. Beijing Tiantan Biological Recent Development
Table 189. Innovent Biologics Company Details
Table 190. Innovent Biologics Business Overview
Table 191. Innovent Biologics Biomanufacturing in Pharmaceutical Product
Table 192. Innovent Biologics Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 193. Innovent Biologics Recent Development
Table 194. Qilu Pharmaceutical Company Details
Table 195. Qilu Pharmaceutical Business Overview
Table 196. Qilu Pharmaceutical Biomanufacturing in Pharmaceutical Product
Table 197. Qilu Pharmaceutical Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 198. Qilu Pharmaceutical Recent Development
Table 199. Boehringer Ingelheim Company Details
Table 200. Boehringer Ingelheim Business Overview
Table 201. Boehringer Ingelheim Biomanufacturing in Pharmaceutical Product
Table 202. Boehringer Ingelheim Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 203. Boehringer Ingelheim Recent Development
Table 204. BeiGene Company Details
Table 205. BeiGene Business Overview
Table 206. BeiGene Biomanufacturing in Pharmaceutical Product
Table 207. BeiGene Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 208. BeiGene Recent Development
Table 209. Jiangsu Hengrui Pharmaceuticals Company Details
Table 210. Jiangsu Hengrui Pharmaceuticals Business Overview
Table 211. Jiangsu Hengrui Pharmaceuticals Biomanufacturing in Pharmaceutical Product
Table 212. Jiangsu Hengrui Pharmaceuticals Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 213. Jiangsu Hengrui Pharmaceuticals Recent Development
Table 214. Hualan Biological Company Details
Table 215. Hualan Biological Business Overview
Table 216. Hualan Biological Biomanufacturing in Pharmaceutical Product
Table 217. Hualan Biological Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 218. Hualan Biological Recent Development
Table 219. Shanghai Henlius Biotech Company Details
Table 220. Shanghai Henlius Biotech Business Overview
Table 221. Shanghai Henlius Biotech Biomanufacturing in Pharmaceutical Product
Table 222. Shanghai Henlius Biotech Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 223. Shanghai Henlius Biotech Recent Development
Table 224. Taibang Biologic Company Details
Table 225. Taibang Biologic Business Overview
Table 226. Taibang Biologic Biomanufacturing in Pharmaceutical Product
Table 227. Taibang Biologic Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 228. Taibang Biologic Recent Development
Table 229. Gan & Lee Pharmaceuticals Company Details
Table 230. Gan & Lee Pharmaceuticals Business Overview
Table 231. Gan & Lee Pharmaceuticals Biomanufacturing in Pharmaceutical Product
Table 232. Gan & Lee Pharmaceuticals Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 233. Gan & Lee Pharmaceuticals Recent Development
Table 234. Anhui Anke Biotechnology Company Details
Table 235. Anhui Anke Biotechnology Business Overview
Table 236. Anhui Anke Biotechnology Biomanufacturing in Pharmaceutical Product
Table 237. Anhui Anke Biotechnology Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 238. Anhui Anke Biotechnology Recent Development
Table 239. Tonghua Dongbao Pharmaceutical Company Details
Table 240. Tonghua Dongbao Pharmaceutical Business Overview
Table 241. Tonghua Dongbao Pharmaceutical Biomanufacturing in Pharmaceutical Product
Table 242. Tonghua Dongbao Pharmaceutical Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 243. Tonghua Dongbao Pharmaceutical Recent Development
Table 244. Shanghai Junshi Biosciences Company Details
Table 245. Shanghai Junshi Biosciences Business Overview
Table 246. Shanghai Junshi Biosciences Biomanufacturing in Pharmaceutical Product
Table 247. Shanghai Junshi Biosciences Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 248. Shanghai Junshi Biosciences Recent Development
Table 249. Sichuan Yuanda Shuyang Pharmaceutical Company Details
Table 250. Sichuan Yuanda Shuyang Pharmaceutical Business Overview
Table 251. Sichuan Yuanda Shuyang Pharmaceutical Biomanufacturing in Pharmaceutical Product
Table 252. Sichuan Yuanda Shuyang Pharmaceutical Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 253. Sichuan Yuanda Shuyang Pharmaceutical Recent Development
Table 254. Kexing Biopharm Company Details
Table 255. Kexing Biopharm Business Overview
Table 256. Kexing Biopharm Biomanufacturing in Pharmaceutical Product
Table 257. Kexing Biopharm Revenue in Biomanufacturing in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 258. Kexing Biopharm Recent Development
Table 259. Research Programs/Design for This Report
Table 260. Key Data Information from Secondary Sources
Table 261. Key Data Information from Primary Sources
Table 262. Authors List of This Report


List of Figures
Figure 1. Biomanufacturing in Pharmaceutical Picture
Figure 2. Global Biomanufacturing in Pharmaceutical Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Biomanufacturing in Pharmaceutical Market Share by Type: 2024 VS 2031
Figure 4. Antibody Drugs Features
Figure 5. Recombinant Protein Drugs Features
Figure 6. Blood Products Features
Figure 7. Vaccine Preparations Features
Figure 8. CAR-T Drugs Features
Figure 9. Small Nucleic Acid Drugs Features
Figure 10. Others Features
Figure 11. Global Biomanufacturing in Pharmaceutical Market Size Comparison by Class (2020-2031) & (US$ Million)
Figure 12. Monoclonal Antibodies Features
Figure 13. Antibody-drug Conjugates (ADCs) Features
Figure 14. Peptide Drugs Features
Figure 15. Enzyme Replacement Therapy Features
Figure 16. Human Albumin Features
Figure 17. Immunoglobulins Features
Figure 18. Coagulation Factors Features
Figure 19. COVID-19 Vaccines Features
Figure 20. Other Vaccines Features
Figure 21. Global Biomanufacturing in Pharmaceutical Market Size by Application (2020-2031) & (US$ Million)
Figure 22. Global Biomanufacturing in Pharmaceutical Market Share by Application: 2024 VS 2031
Figure 23. Oncology Case Studies
Figure 24. Infectious Diseases Case Studies
Figure 25. Immune and Inflammatory Diseases Case Studies
Figure 26. Endocrine and Metabolic Diseases Case Studies
Figure 27. Neurological Diseases Case Studies
Figure 28. Hematologic Diseases Case Studies
Figure 29. Others Case Studies
Figure 30. Biomanufacturing in Pharmaceutical Report Years Considered
Figure 31. Global Biomanufacturing in Pharmaceutical Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 32. Global Biomanufacturing in Pharmaceutical Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 33. Global Biomanufacturing in Pharmaceutical Market Share by Region: 2024 VS 2031
Figure 34. Global Biomanufacturing in Pharmaceutical Market Share by Players in 2024
Figure 35. Global Biomanufacturing in Pharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 36. The Top 10 and 5 Players Market Share by Biomanufacturing in Pharmaceutical Revenue in 2024
Figure 37. North America Biomanufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. North America Biomanufacturing in Pharmaceutical Market Share by Country (2020-2031)
Figure 39. United States Biomanufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Canada Biomanufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Europe Biomanufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Europe Biomanufacturing in Pharmaceutical Market Share by Country (2020-2031)
Figure 43. Germany Biomanufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. France Biomanufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. U.K. Biomanufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Italy Biomanufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Russia Biomanufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Ireland Biomanufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Asia-Pacific Biomanufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Biomanufacturing in Pharmaceutical Market Share by Region (2020-2031)
Figure 51. China Biomanufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Japan Biomanufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. South Korea Biomanufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. Southeast Asia Biomanufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 55. India Biomanufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 56. Australia & New Zealand Biomanufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 57. Latin America Biomanufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 58. Latin America Biomanufacturing in Pharmaceutical Market Share by Country (2020-2031)
Figure 59. Mexico Biomanufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 60. Brazil Biomanufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 61. Middle East & Africa Biomanufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 62. Middle East & Africa Biomanufacturing in Pharmaceutical Market Share by Country (2020-2031)
Figure 63. Israel Biomanufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 64. Saudi Arabia Biomanufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 65. UAE Biomanufacturing in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 66. Roche Revenue Growth Rate in Biomanufacturing in Pharmaceutical Business (2020-2025)
Figure 67. Merck Revenue Growth Rate in Biomanufacturing in Pharmaceutical Business (2020-2025)
Figure 68. Novo Nordisk Revenue Growth Rate in Biomanufacturing in Pharmaceutical Business (2020-2025)
Figure 69. Sanofi Revenue Growth Rate in Biomanufacturing in Pharmaceutical Business (2020-2025)
Figure 70. Johnson & Johnson Revenue Growth Rate in Biomanufacturing in Pharmaceutical Business (2020-2025)
Figure 71. AbbVie Revenue Growth Rate in Biomanufacturing in Pharmaceutical Business (2020-2025)
Figure 72. Amgen Revenue Growth Rate in Biomanufacturing in Pharmaceutical Business (2020-2025)
Figure 73. AstraZeneca Revenue Growth Rate in Biomanufacturing in Pharmaceutical Business (2020-2025)
Figure 74. Takeda Pharmaceuticals Revenue Growth Rate in Biomanufacturing in Pharmaceutical Business (2020-2025)
Figure 75. Bristol-Myers Squib Revenue Growth Rate in Biomanufacturing in Pharmaceutical Business (2020-2025)
Figure 76. Pfizer Revenue Growth Rate in Biomanufacturing in Pharmaceutical Business (2020-2025)
Figure 77. Eli Lilly Revenue Growth Rate in Biomanufacturing in Pharmaceutical Business (2020-2025)
Figure 78. Novartis Revenue Growth Rate in Biomanufacturing in Pharmaceutical Business (2020-2025)
Figure 79. GSK Revenue Growth Rate in Biomanufacturing in Pharmaceutical Business (2020-2025)
Figure 80. CSL Limited Revenue Growth Rate in Biomanufacturing in Pharmaceutical Business (2020-2025)
Figure 81. Regeneron Pharmaceuticals Revenue Growth Rate in Biomanufacturing in Pharmaceutical Business (2020-2025)
Figure 82. Gilford Revenue Growth Rate in Biomanufacturing in Pharmaceutical Business (2020-2025)
Figure 83. Biogen Revenue Growth Rate in Biomanufacturing in Pharmaceutical Business (2020-2025)
Figure 84. GileadSciences Revenue Growth Rate in Biomanufacturing in Pharmaceutical Business (2020-2025)
Figure 85. Moderna Revenue Growth Rate in Biomanufacturing in Pharmaceutical Business (2020-2025)
Figure 86. Sarepta Therapeutics, Inc. Revenue Growth Rate in Biomanufacturing in Pharmaceutical Business (2020-2025)
Figure 87. Changchun High-Tech Industry Revenue Growth Rate in Biomanufacturing in Pharmaceutical Business (2020-2025)
Figure 88. Sino Biopharmaceutical Limited Revenue Growth Rate in Biomanufacturing in Pharmaceutical Business (2020-2025)
Figure 89. Sobi Revenue Growth Rate in Biomanufacturing in Pharmaceutical Business (2020-2025)
Figure 90. 3SBio Inc. Revenue Growth Rate in Biomanufacturing in Pharmaceutical Business (2020-2025)
Figure 91. Beijing Tiantan Biological Revenue Growth Rate in Biomanufacturing in Pharmaceutical Business (2020-2025)
Figure 92. Innovent Biologics Revenue Growth Rate in Biomanufacturing in Pharmaceutical Business (2020-2025)
Figure 93. Qilu Pharmaceutical Revenue Growth Rate in Biomanufacturing in Pharmaceutical Business (2020-2025)
Figure 94. Boehringer Ingelheim Revenue Growth Rate in Biomanufacturing in Pharmaceutical Business (2020-2025)
Figure 95. BeiGene Revenue Growth Rate in Biomanufacturing in Pharmaceutical Business (2020-2025)
Figure 96. Jiangsu Hengrui Pharmaceuticals Revenue Growth Rate in Biomanufacturing in Pharmaceutical Business (2020-2025)
Figure 97. Hualan Biological Revenue Growth Rate in Biomanufacturing in Pharmaceutical Business (2020-2025)
Figure 98. Shanghai Henlius Biotech Revenue Growth Rate in Biomanufacturing in Pharmaceutical Business (2020-2025)
Figure 99. Taibang Biologic Revenue Growth Rate in Biomanufacturing in Pharmaceutical Business (2020-2025)
Figure 100. Gan & Lee Pharmaceuticals Revenue Growth Rate in Biomanufacturing in Pharmaceutical Business (2020-2025)
Figure 101. Anhui Anke Biotechnology Revenue Growth Rate in Biomanufacturing in Pharmaceutical Business (2020-2025)
Figure 102. Tonghua Dongbao Pharmaceutical Revenue Growth Rate in Biomanufacturing in Pharmaceutical Business (2020-2025)
Figure 103. Shanghai Junshi Biosciences Revenue Growth Rate in Biomanufacturing in Pharmaceutical Business (2020-2025)
Figure 104. Sichuan Yuanda Shuyang Pharmaceutical Revenue Growth Rate in Biomanufacturing in Pharmaceutical Business (2020-2025)
Figure 105. Kexing Biopharm Revenue Growth Rate in Biomanufacturing in Pharmaceutical Business (2020-2025)
Figure 106. Bottom-up and Top-down Approaches for This Report
Figure 107. Data Triangulation
Figure 108. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit